Ocugen (FRA:2H51) Long-Term Debt : €1.42 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Ocugen Long-Term Debt?

Ocugen's Long-Term Debt for the quarter that ended in Sep. 2024 was €1.42 Mil.

Ocugen's quarterly Long-Term Debt increased from Mar. 2024 (€1.41 Mil) to Jun. 2024 (€1.44 Mil) but then declined from Jun. 2024 (€1.44 Mil) to Sep. 2024 (€1.42 Mil).

Ocugen's annual Long-Term Debt increased from Dec. 2021 (€1.52 Mil) to Dec. 2022 (€2.16 Mil) and increased from Dec. 2022 (€2.16 Mil) to Dec. 2023 (€2.57 Mil).

Ocugen Long-Term Debt Historical Data

The historical data trend for Ocugen's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen Long-Term Debt Chart

Ocugen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

0.97

1.50

1.52

2.16

2.57

Ocugen Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															1.40	2.57	1.41	1.44	1.42

Ocugen (FRA:2H51) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Ocugen Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Ocugen's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocugen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (FRA:2H51) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

OCGN:USA OCGN:Mexico

Address

11 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.ocugen.com

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen Headlines

No Headlines